menu
    • menu

    Company profile for Dexcom

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 1999, Dexcom, Inc. is transforming diabetes care and management by providing superior continuous glucose monitoring (CGM) technology to help patients and healthcare professionals better manage diabetes. Since our inception, we have focused on better outcomes for patients, caregivers, and clinicians by delivering solutions that are best in class - while empowering our community to take control of diabetes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    DexcomUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    6340 Sequence Drive San Diego, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.dexcom.com/en-IN
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dexcom/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BioAsia

    Not Confirmed

    envelop Contact Supplier

    BioAsia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dexcom Releases 2025 Q4 And Fiscal Year Financials
    Dexcom Releases 2025 Q4 And Fiscal Year Financials

    12 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260212038745/en/Dexcom-Reports-Fourth-Quarter-and-Fiscal-Year-2025-Financial-Results

    BUSINESSWIRE
    12 Feb 2026
    Share Share
    Dexcom Enhances Smart Meal Logging; Stelo Boosts Glucose
    Dexcom Enhances Smart Meal Logging; Stelo Boosts Glucose

    04 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260204086490/en/Stelo-Adds-Enhanced-Smart-Meal-Logging-Features-as-Dexcom-Continues-to-Transform-Personal-Glucose-Management

    BUSINESSWIRE
    04 Feb 2026
    Share Share
    Dexcom to Report Q4, FY 2025 Earnings Feb. 12, 2026
    Dexcom to Report Q4, FY 2025 Earnings Feb. 12, 2026

    27 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260127817991/en/Dexcom-Schedules-Fourth-Quarter-and-Fiscal-Year-2025-Earnings-Release-and-Conference-Call-for-February-12-2026-at-430-p.m.-Eastern-Time.

    BUSINESSWIRE
    27 Jan 2026
    Share Share
    Dexcom CEO Outlines Plan To Stop A Repeat Of G7 Supply Shortage
    Dexcom CEO Outlines Plan To Stop A Repeat Of G7 Supply Shortage

    13 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/dexcoms-new-ceo-outlines-resilience-approach-stop-repeat-g7-supply-shortage

    FIERCE BIOTECH
    13 Jan 2026
    Share Share
    Dexcom: Prelim Unaudited Q4, FY25 Results & Initial 2026 Outlook
    Dexcom: Prelim Unaudited Q4, FY25 Results & Initial 2026 Outlook

    12 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260112293861/en/Dexcom-Reports-Preliminary-Unaudited-Results-for-the-Fourth-Quarter-and-Fiscal-Year-2025-and-Initial-2026-Outlook

    BUSINESSWIRE
    12 Jan 2026
    Share Share
    Dexcom Ushers In Innovation Era Under CEO Jake Leach
    Dexcom Ushers In Innovation Era Under CEO Jake Leach

    07 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260107580853/en/Dexcom-Enters-Next-Era-of-Continued-Innovation-With-Jake-Leach-as-President-and-Chief-Executive-Officer

    BUSINESSWIRE
    07 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search